In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

28:1446 Petition for Removal- Personal Injury

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 09, 2020

    Drug Cos. Fight Class Cert. For 'Opioid Babies' In MDL

    Drugmakers and retailers facing multidistrict litigation over their alleged role in the opioid epidemic urged a federal judge Friday not to certify a class of legal guardians of babies born to mothers who took opioids during pregnancy, saying their personal injury claims can't be resolved collectively.

  2. October 09, 2020

    Opioid MDL Bellwether Trial Delayed Amid COVID-19 Fears

    Amid coronavirus concerns, a West Virginia federal judge on Friday postponed an eagerly awaited bellwether trial in multidistrict opioid litigation shortly before its scheduled start, adding to a series of recent setbacks for local governments that blame drug companies for rampant addiction.

  3. October 09, 2020

    Negotiation Class Wants 6th Circ. Full Review In Opioid MDL

    A proposed negotiation class intended to seek settlements in the sprawling Ohio multidistrict litigation over the national opioid crisis is urging the Sixth Circuit for a full-court review of a decision last month striking the class down, saying the split panel went against the intent of federal class rules and its own precedent.

  4. October 08, 2020

    Pandemic Can't Delay Landmark Opioid Trial, Judge Told

    The first bellwether trial in multidistrict opioid litigation must start this month because an epidemic of painkiller addiction is just as deadly as the coronavirus pandemic, and drug companies are exaggerating the virus threat, local governments told a West Virginia judge late Thursday.

  5. October 05, 2020

    Drug Distributors Fear 'Super-Spreader' Trial In Opioid MDL

    Major drug distributors on Monday asked a West Virginia federal judge to delay an imminent bellwether trial in multidistrict opioid litigation by warning of a coronavirus "super-spreader" outbreak, while in Ohio a federal judge postponed another bellwether trial in the MDL because of COVID-19 concerns.

  6. September 22, 2020

    Pharmacies Lose Bid To Revisit Ruling On Their Opioid Duties

    The Ohio federal judge overseeing opioid litigation on Tuesday refused to reconsider an earlier decision allowing two Ohio counties' opioid claims to go forward, reaffirming his conclusion that pharmacies should protect against types of diversion beyond theft.

  7. September 08, 2020

    Ohio Counties Blast Pharmacies' Review Bid In Opioid MDL

    Pharmacies have no justification for their request that the Sixth Circuit review a judge's ruling allowing two Ohio counties' opioid claims to go forward, other than that they disagree with the ruling, the counties said Tuesday.

  8. September 04, 2020

    Teva's $23B Opioid Litigation Deal Faces New Wave Of Attacks

    Teva's offer to settle thousands of opioid-crisis lawsuits by donating enough opioid-dependence drugs to satisfy most U.S. demand for 10 years is attracting sharp new criticism from a bipartisan assortment of public officials who warn it could crush a vital and highly competitive corner of the pharmaceutical industry, interviews and documents show.

  9. September 01, 2020

    Allergan, Teva Accused Of Hiding 'Critical' Opioid Info

    A group of Ohio cities and counties asked the federal judge overseeing the opioid multidistrict litigation to sanction Teva and Allergan for the "willful" failure to produce an audit report over suspicious orders of opioids during discovery.

  10. August 26, 2020

    Pharmacies Torch 'Unprecedented' Ruling On Opioid Duties

    Pharmacy chains on Tuesday lashed out at a recent order by an Ohio federal judge allowing two Ohio counties' opioid claims to go forward, saying that the judge interpreted the Controlled Substances Act in a "far-reaching" way that should be reviewed by the Sixth Circuit if the ruling isn't reversed.